Owing to autoantibody production and thrombophilic disorders in COVID-19, physicians must have low threshold to investigate secondary IIH and demyelinating disorders in patients with headache and decreased vision following recent COVID-19 infection.
Keywords: COVID‐19; NMOSD; SARS‐CoV‐2; anti‐MOG syndrome; coronavirus; neurological manifestations; pseudotumor cerebri.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.